Cynata Therapeutics Ltd has released a press release.
Positive Data from CYP MSCs in 2nd Preclinical Asthma Study
Filed with ASX ·
6ix hasn’t read this filing yet.
Cynata Therapeutics Limited on 6ix
Story so far
Earlier from Cynata Therapeutics
- June 2017 Quarterly Report
- FDA Meeting Provides Clear Path for US Development Plans
- Cynata Therapeutics GvHD Clinical Trial & Corporate Progress
- CYP MSC Data in Asthma Model Published in Sceintific Journal
- Cynata Files New Patent Application for Cymerus in Oncology
Later from Cynata Therapeutics
- Health Canada Meeting Advances CYP Global Development Plans
- US Patent Granted for Cynata Cymerus Technology
- Cynata to Increase Exposure in Japan
- Notice of Annual General Meeting/Proxy Form
- September 2017 Quarterly Report
Follow Cynata Therapeutics into a list and get an email when it puts out news.
Follow Cynata Therapeutics